325 related articles for article (PubMed ID: 23154300)
1. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
Bjørgaas MR; Farstad H; Christiansen SC; Blaas HG
Horm Res Paediatr; 2013; 79(1):39-43. PubMed ID: 23154300
[TBL] [Abstract][Full Text] [Related]
2. [Hyperthyroidism in a premature infant due to transplacental passage of maternal thyrotropin receptor antibodies].
Rink T; Wieg C; Schroth HJ; Helisch A; Bertram U
Nuklearmedizin; 1999; 38(5):156-9. PubMed ID: 10488483
[TBL] [Abstract][Full Text] [Related]
3. Three Consecutive Pregnancies in a Patient with Chronic Autoimmune Thyroid Disease Associated with Hypothyroidism and Extremely High Levels of Anti-Thyrotropin Receptor Antibodies.
Grulet H; Barraud S; Chikh K; Souchon PF; Claris O; Bouvier R; Trouillas J; Gabriel R; Bory JP; Schvartz C; Orgiazzi J; Delemer B
Thyroid; 2019 May; 29(5):743-747. PubMed ID: 30973063
[No Abstract] [Full Text] [Related]
4. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
5. Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism.
Hamada N; Momotani N; Ishikawa N; Yoshimura Noh J; Okamoto Y; Konishi T; Ito K; Ito K
Endocr J; 2011; 58(1):55-8. PubMed ID: 20962435
[TBL] [Abstract][Full Text] [Related]
6. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
[TBL] [Abstract][Full Text] [Related]
9. Fetal and neonatal hyperthyroidism.
Zimmerman D
Thyroid; 1999 Jul; 9(7):727-33. PubMed ID: 10447021
[TBL] [Abstract][Full Text] [Related]
10. Third-Generation Thyrotropin Receptor Antibody (TRAb) assay for predicting neonatal thyroid dysfunction in pregnant women with Graves' disease.
Priyanka R; Sridhar S; Sumathi B; Jeyaraj AR; Natarajan V; Subbiah E; Raghavan KS; Sangumani J
Endocrine; 2024 May; 84(2):500-508. PubMed ID: 37861945
[TBL] [Abstract][Full Text] [Related]
11. TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease.
Suzuki N; Yoshihara A; Yoshimura Noh J; Kinoshita K; Ohnishi J; Saito M; Sugino K; Ito K
Endocr J; 2020 Oct; 67(10):1019-1022. PubMed ID: 32522908
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
13. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
[TBL] [Abstract][Full Text] [Related]
14. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
Nachum Z; Rakover Y; Weiner E; Shalev E
Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
[TBL] [Abstract][Full Text] [Related]
15. [Pregnancy and the thyroid gland].
Lieutaud H
Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
[TBL] [Abstract][Full Text] [Related]
16. Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations.
Volpé R; Ehrlich R; Steiner G; Row VV
Am J Med; 1984 Sep; 77(3):572-8. PubMed ID: 6548082
[TBL] [Abstract][Full Text] [Related]
17. Foetal and neonatal thyroid disorders.
Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
[TBL] [Abstract][Full Text] [Related]
18. Fetal cord blood sampling in the diagnosis and the treatment of fetal hyperthyroidism in the offsprings of a euthyroid mother, producing thyroid stimulating immunoglobulins.
Polak M; Leger J; Luton D; Oury JF; Vuillard E; Boissinot C; Czernichow P
Ann Endocrinol (Paris); 1997; 58(4):338-42. PubMed ID: 9436485
[TBL] [Abstract][Full Text] [Related]
19. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
20. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]